Literature DB >> 9360955

Zinc inhibition of mitochondrial aconitase and its importance in citrate metabolism of prostate epithelial cells.

L C Costello1, Y Liu, R B Franklin, M C Kennedy.   

Abstract

Prostate epithelial cells possess a uniquely limiting mitochondrial (m-) aconitase activity that minimizes their ability to oxidize citrate. These cells also possess uniquely high cellular and mitochondrial zinc levels. Correlations among zinc, citrate, and m-aconitase in prostate indicated that zinc might be an inhibitor of prostate m-aconitase activity and citrate oxidation. The present studies reveal that zinc at near physiological levels inhibited m-aconitase activity of mitochondrial sonicate preparations obtained from rat ventral prostate epithelial cells. Corresponding studies conducted with mitochondrial sonicates of rat kidney cells revealed that zinc also inhibited the kidney m-aconitase activity. However the inhibitory effect of zinc was more sensitive with the prostate m-aconitase activity. Zinc inhibition fit the competitive inhibitor model. The inhibitory effect of zinc occurred only with citrate as substrate and was specific for the citrate --> cis-aconitate reaction. Other cations (Ca2+, Mn2+, Cd2+) did not result in the inhibitory effects obtained with zinc. The presence of endogenous zinc inhibited the m-aconitase activity of the prostate mitochondrial preparations. Kidney preparations that contain lower endogenous zinc levels exhibited no endogenous inhibition of m-aconitase activity. Studies with pig prostate and seminal vesicle mitochondrial preparations also revealed that zinc was a competitive inhibitor against citrate of m-aconitase activity. The effects of zinc on purified beef heart m-aconitase verified the competitive inhibitor action of zinc. In contrast, zinc had no inhibitory effect on purified cytosolic aconitase. These studies reveal for the first time that zinc is a specific inhibitor of m-aconitase of mammalian cells. In prostate epithelial cells, in situ mitochondrial zinc levels inhibit m-aconitase activity, which provides a mechanism by which citrate oxidation is limited.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9360955     DOI: 10.1074/jbc.272.46.28875

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  82 in total

Review 1.  The intermediary metabolism of the prostate: a key to understanding the pathogenesis and progression of prostate malignancy.

Authors:  L C Costello; R B Franklin
Journal:  Oncology       Date:  2000-11       Impact factor: 2.935

Review 2.  Role of zinc in the pathogenesis and treatment of prostate cancer: critical issues to resolve.

Authors:  L C Costello; P Feng; B Milon; M Tan; R B Franklin
Journal:  Prostate Cancer Prostatic Dis       Date:  2004       Impact factor: 5.554

Review 3.  Zinc in specialized secretory tissues: roles in the pancreas, prostate, and mammary gland.

Authors:  Shannon L Kelleher; Nicholas H McCormick; Vanessa Velasquez; Veronica Lopez
Journal:  Adv Nutr       Date:  2011-03-10       Impact factor: 8.701

Review 4.  Metabolomic profiling of hormone-dependent cancers: a bird's eye view.

Authors:  Stacy M Lloyd; James Arnold; Arun Sreekumar
Journal:  Trends Endocrinol Metab       Date:  2015-08-01       Impact factor: 12.015

5.  Mitochondrial aconitase gene expression is regulated by testosterone and prolactin in prostate epithelial cells .

Authors:  L C Costello; Y Liu; J Zou; R B Franklin
Journal:  Prostate       Date:  2000-02-15       Impact factor: 4.104

6.  Assessing prostate cancer growth with citrate measured by intact tissue proton magnetic resonance spectroscopy.

Authors:  R Dittrich; J Kurth; E A Decelle; E M DeFeo; M Taupitz; S Wu; C-L Wu; W S McDougal; L L Cheng
Journal:  Prostate Cancer Prostatic Dis       Date:  2012-01-31       Impact factor: 5.554

Review 7.  Zinc and zinc transporters in normal prostate and the pathogenesis of prostate cancer.

Authors:  Renty B Franklin; Beatrice Milon; Pei Feng; Leslie C Costello
Journal:  Front Biosci       Date:  2005-09-01

Review 8.  Mitochondrial function, zinc, and intermediary metabolism relationships in normal prostate and prostate cancer.

Authors:  L C Costello; R B Franklin; Pei Feng
Journal:  Mitochondrion       Date:  2005-06       Impact factor: 4.160

9.  Zinc intake from supplements and diet and prostate cancer.

Authors:  Alejandro Gonzalez; Ulrike Peters; Johanna W Lampe; Emily White
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

10.  Kinetic identification of a mitochondrial zinc uptake transport process in prostate cells.

Authors:  Zhixin Guan; Boone Kukoyi; Pei Feng; M Claire Kennedy; Renty B Franklin; Leslie C Costello
Journal:  J Inorg Biochem       Date:  2003-10-01       Impact factor: 4.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.